1-[4-({2-[(2-methylprop-2-en-1-yl)oxy]ethyl}amino)phenyl]ethan-1-one

Catalog No. :
ACKMLL153
CAS No. :
1707756-35-1
Molecular Formula :
C14H19NO2
Molecular Weight :
233.31

IUPAC Name:1-(4-((2-((2-methylallyl)oxy)ethyl)amino)phenyl)ethan-1-one

1-[4-({2-[(2-methylprop-2-en-1-yl)oxy]ethyl}amino)phenyl]ethan-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$243.00Login to see priceInquiryInquiry
100mg95%$354.00Login to see priceInquiryInquiry
250mg95%$498.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[4-({2-[(2-methylprop-2-en-1-yl)oxy]ethyl}amino)phenyl]ethan-1-one
IUPAC Name1-(4-((2-((2-methylallyl)oxy)ethyl)amino)phenyl)ethan-1-one
MDL No.MFCD27500695
Molecular FormulaC14H19NO2
Molecular Weight233.31
SMILESCC(C1=CC=C(NCCOCC(C)=C)C=C1)=O
InChI KeyHDQDGKRSYXOSCN-UHFFFAOYSA-N
Synonym1-[4-({2-[(2-methylprop-2-en-1-yl)oxy]ethyl}amino)phenyl]ethan-1-one;Ethanone, 1-[4-[[2-[(2-methyl-2-propen-1-yl)oxy]ethyl]amino]phenyl]-
CAS No.1707756-35-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACKMLL153 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXZPN065 route compound structure diagram
    ACXZPN065403-42-9 In Stock
  4. Then
  5. ACKMLL153 route product structure diagram
    ACKMLL1531707756-35-1
Inquiry

2. ACKMLL153 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVRPQ271 route compound structure diagram
    ACVRPQ27199-92-3 In Stock
  4. Then
  5. ACKMLL153 route product structure diagram
    ACKMLL1531707756-35-1
Inquiry

Comments (0)